|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019829,
umls-concept:C0030705,
umls-concept:C0033325,
umls-concept:C0054950,
umls-concept:C0205210,
umls-concept:C0205250,
umls-concept:C0229671,
umls-concept:C0441889,
umls-concept:C0680220,
umls-concept:C1456796,
umls-concept:C1705984,
umls-concept:C1749467,
umls-concept:C2348519
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1994-5-12
|
|
pubmed:abstractText |
To evaluate the serum levels of the soluble form of the CD30 molecule (sCD30) in patients with Hodgkin's disease (HD) to establish whether there is a correlation with clinical features at presentation and prognosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
793-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8151321-Adolescent,
pubmed-meshheading:8151321-Adult,
pubmed-meshheading:8151321-Aged,
pubmed-meshheading:8151321-Aged, 80 and over,
pubmed-meshheading:8151321-Analysis of Variance,
pubmed-meshheading:8151321-Antigens, CD30,
pubmed-meshheading:8151321-Child,
pubmed-meshheading:8151321-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8151321-Female,
pubmed-meshheading:8151321-Hodgkin Disease,
pubmed-meshheading:8151321-Humans,
pubmed-meshheading:8151321-Male,
pubmed-meshheading:8151321-Middle Aged,
pubmed-meshheading:8151321-Prognosis,
pubmed-meshheading:8151321-Proportional Hazards Models,
pubmed-meshheading:8151321-Survival Analysis
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
|
|
pubmed:affiliation |
Department of Hematology, Verona University School of Medicine, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
